調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023

幹細胞アッセイの世界市場予測（～2023年）

◆タイトル：Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023
◆商品コード：MAM-BT-4628
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年3月28日
◆ページ数：226
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥920,950見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、細胞タイプ別分析、製品別分析、用途別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments.
The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the global stem cell assay market in 2017. Factors driving the growth of this segment include the widespread use of viability/cytotoxicity assays in stem cell research activities.

By cell type, the market is segmented into adult stem cells and human embryonic stem cells. The adult stem cells segment accounted for the largest market share of the global stem cell assay market in 2017. Increasing research on adult stem cells and less stringent regulations are the key factors driving the growth of the adult stem cell market.

On the basis of product & service, the stem cell assay market is segmented into instruments, kits, and services. The instruments segment is estimated to account for the largest share of the global stem cell assay market during the forecast period. The growth of this segment is primarily attributed to the ongoing technological innovations in stem cell instruments and the rising number of stem cell research activities across the globe.

By application, the stem cell assay market is classified into regenerative medicine and therapy development; drug discovery and development; and clinical research. The regenerative medicine and therapy development segment is estimated to account for the largest share of the global stem cell assay market in the next five years. The large share of this segment can be attributed to the growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies.

On the basis of end user, the stem cell assay market is segmented into biopharmaceutical & biotechnology companies; and research institutes. The biopharmaceutical & biotechnology companies segment is estimated to account for the largest share of the global stem cell assay market. Growth in the number of biopharmaceutical and biotechnology companies globally, along with the increasing demand for novel cell therapies are driving the growth of this segment.

Stem Cell Assay Market

The global stem cell assay market is dominated by North America, followed by Europe. North America will continue to dominate the global stem cell assay market in the forecast period. Moreover, this region is also expected to witness the highest CAGR during the forecast period. North America’s large share and growth can be attributed to the favorable regulatory guidelines in the region, growing awareness about stem cell assays, the presence of a large number of market players, and increasing government investments in the field.
The factors such as the high degree of consolidation and a complex regulatory framework for the approval of new products may restrain the market’s growth to a certain extent.

Major industry players adopted product launches and partnerships & agreements to maintain and improve their position in the stem cell assay market. Thermo Fisher Scientific (US), Merck (Germany), GE Healthcare (US), Bio-Rad Laboratories (US), and Promega Corporation (US) have been identified as key players in this market. These companies have a broad product portfolio with comprehensive features and have also expanded their presence geographically. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

【レポートの目次】

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 35)
4.1 Stem Cell Assays Market Overview
4.2 Asia Pacific: Stem Cell Assays Market, By Instrument & Country
4.3 Stem Cell Assays Market, By Type
4.4 Geographical Snapshot of the Stem Cell Assays Market (By Major Countries)

5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Availability of Funding for Stem Cell Research
5.2.1.2 Rising Incidence of Target Indications
5.2.1.3 Technological Advancements in Stem Cell-Based Research Instruments and Introduction of Novel Stem Cell Products
5.2.1.4 Growth of End-Use Industries
5.2.2 Restraints
5.2.2.1 Ethical Issues Related to Embryonic Stem Cell Research
5.2.2.2 High Cost of Stem Cell Analysis Instruments and Reagents
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Economies
5.2.3.2 Emergence of Microfluidics in Stem Cell Research
5.2.3.3 High Growth Potential of Single Stem Cell Analysis Sequencing
5.2.4 Challenges
5.2.4.1 Complexities Related to Antibody and Reagent Development
5.2.4.2 Survival of Small Players and New Entrants
5.3 Technology Roadmap
5.3.1 Microfabrication-Assisted Technologies
5.3.1.1 Microfluidics-Based Cell Trap Technology
5.3.1.2 Droplet-Based Microfluidic Technology
5.3.1.3 Microwell-Based Analysis Systems
5.3.2 Advanced Technology
5.3.2.1 Bead-Based Multiplex Assays

6 Stem Cell Assays Market, By Type (Page No. – 49)
6.1 Introduction
6.2 Viability/Cytotoxicty Assays
6.3 Isolation & Purification Assays
6.4 Cell Identification Assays
6.5 Proliferation Assays
6.6 Differentiation Assays
6.7 Function Assays
6.8 Apoptosis Assays

7 Stem Cell Assays Market, By Cell Type (Page No. – 58)
7.1 Introduction
7.2 Adult Stem Cells
7.2.1 Adult Stem Cells Market, By Type
7.2.1.1 Mesenchymal Stem Cells
7.2.1.2 Induced Pluripotent Stem Cells
7.2.1.3 Hematopoietic Stem Cells
7.2.1.4 Umbilical Cord Stem Cells
7.2.1.5 Neural Stem Cells
7.3 Human Embryonic Stem Cells

8 Stem Cell Assays Market, By Product & Service (Page No. – 68)
8.1 Introduction
8.2 Instruments
8.2.1 Instruments Market, By Type
8.2.1.1 Flow Cytometers
8.2.1.2 Microelectrode Arrays
8.2.1.3 Cell Imaging Systems
8.2.1.4 Automated Cell Counters
8.3 Kits
8.4 Services

9 Stem Cell Assays Market, By Application (Page No. – 78)
9.1 Introduction
9.2 Regenerative Medicine & Therapy Development
9.2.1 Orthopedic & Musculoskeletal Spine Applications
9.2.2 Dermatology
9.2.3 Cardiovascular Applications
9.2.4 Central Nervous System Applications
9.2.5 Oncology
9.2.6 Diabetes
9.2.7 Other Applications
9.3 Drug Discovery & Development
9.4 Clinical Research

10 Stem Cell Assays Market, By End User (Page No. – 89)
10.1 Introduction
10.2 Biopharmaceutical & Biotechnology Companies
10.3 Research Institutes

11 Global Stem Cell Assays Market, By Region (Page No. – 94)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Switzerland
11.3.7 Rest of Europe (RoE)
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape (Page No. – 183)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product Launches
12.3.2 Partnerships & Agreements
12.3.3 Acquisitions
12.3.4 Expansions

13 Company Profiles (Page No. – 188)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Thermo Fisher Scientific
13.2 Merck
13.3 GE Healthcare
13.4 Bio-Rad Laboratories
13.5 Promega Corporation
13.6 Agilent Technologies
13.7 Perkinelmer
13.8 Miltenyi Biotec
13.9 Cell Biolabs
13.10 Hemogenix
13.11 Stemcell Technologies
13.12 Bio-Techne Corporation
13.13 Cellular Dynamics International (CDI)

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 215)
14.1 Industry Insights
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details

List of Tables (188 Tables)

Table 1 List of Diseases That Can Be Treated Using Stem Cells
Table 2 Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 3 Viability/Cytotoxicty Assays Market, By Region, 2016–2023 (USD Million)
Table 4 Isolation & Purification Assays Market, By Region, 2016–2023 (USD Million)
Table 5 Cell Identification Assays Market, By Region, 2016–2023 (USD Million)
Table 6 Proliferation Assays Market, By Region, 2016–2023 (USD Million)
Table 7 Differentiation Assays Market, By Region, 2016–2023 (USD Million)
Table 8 Function Assays Market, By Region, 2016–2023 (USD Million)
Table 9 Apoptosis Assays Market, By Region, 2016–2023 (USD Million)
Table 10 Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 11 Adult Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 12 Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 13 Mesenchymal Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 14 Induced Pluripotent Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 15 Hematopoietic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 16 Umbilical Cord Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 17 Neural Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 18 Human Embryonic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 19 Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 20 Stem Cell Assay Instruments Market, By Region, 2016–2023 (USD Million)
Table 21 Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 22 Flow Cytometers Market, By Region, 2016–2023 (USD Million)
Table 23 Microelectrode Arrays Market, By Region, 2016–2023 (USD Million)
Table 24 Cell Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 25 Automated Cell Counters Market, By Region, 2016–2023 (USD Million)
Table 26 Stem Cell Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 27 Stem Cell Assay Services Market, By Region, 2016–2023 (USD Million)
Table 28 Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 29 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Region, 2016–2023 (USD Million)
Table 30 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 31 Orthopedic & Musculoskeletal Spine Applications Market, By Region, 2016–2023 (USD Million)
Table 32 Dermatology Applications Market, By Region, 2016–2023 (USD Million)
Table 33 Cardiovascular Applications Market, By Region, 2016–2023 (USD Million)
Table 34 Central Nervous System Applications Market, By Region, 2016–2023 (USD Million)
Table 35 Oncology Applications Market, By Region, 2016–2023 (USD Million)
Table 36 Diabetes Applications Market, By Region, 2016–2023 (USD Million)
Table 37 Other Regenerative Medicine & Therapy Development Applications Market, By Region, 2016–2023 (USD Million)
Table 38 Stem Cell Assays Market for Drug Discovery & Development, By Region, 2016–2023 (USD Million)
Table 39 Stem Cell Assays Market for Clinical Research, By Region, 2016–2023 (USD Million)
Table 40 Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 41 Stem Cell Assays Market for Biopharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 42 Stem Cell Assays Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 43 Stem Cell Assays Market, By Region, 2016–2023 (USD Million)
Table 44 North America: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 45 North America: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 46 North America: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 47 North America: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 48 North America: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 49 North America: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 North America: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 51 North America: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 52 North America: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 53 Incidence & Prevalence of Target Diseases (2017)
Table 54 Timelines of Major Events in Stem Cell Research Policy (2011 – 2017)
Table 55 US: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 56 US: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 57 US: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 58 US: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 59 US: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 60 US: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 61 US: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 62 US: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 63 Canada: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 64 Canada: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 65 Canada: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 66 Canada: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 67 Canada: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 68 Canada: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 69 Canada: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 70 Canada: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 71 Europe: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 72 Europe: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 73 Europe: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 74 Europe: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 75 Europe: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 76 Europe: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 Europe: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 78 Europe: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 79 Europe: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 80 Germany: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 81 Germany: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 82 Germany: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 83 Germany: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 84 Germany: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 85 Germany: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 86 Germany: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 87 Germany: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 88 UK: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 89 UK: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 90 UK: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 91 UK: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 92 UK: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 93 UK: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 94 UK: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 95 UK: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 96 France: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 97 France: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 98 France: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 99 France: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 100 France: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 101 France: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 102 France: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 103 France: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 104 Spain: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 105 Spain: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 106 Spain: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 107 Spain: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 108 Spain: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 109 Spain: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 110 Spain: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 111 Spain: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 112 Italy: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 113 Italy: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 114 Italy: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 115 Italy: Stem Cell Assays Market, By Product & Service 2016–2023 (USD Million)
Table 116 Italy: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 117 Italy: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 118 Italy: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 119 Italy: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 120 Switzerland: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 121 Switzerland: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 122 Switzerland: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 123 Switzerland: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 124 Switzerland: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 125 Switzerland: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 126 Switzerland: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 127 Switzerland: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 128 RoE: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 129 RoE: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 130 RoE: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 131 RoE: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 132 RoE: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 133 RoE: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 134 RoE: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 135 RoE: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 136 Asia Pacific: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 137 Asia Pacific: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 138 Asia Pacific: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 139 Asia Pacific: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 140 Asia Pacific: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 141 Asia Pacific: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 142 Asia Pacific: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 143 Asia Pacific: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 144 Asia Pacific: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 145 China: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 146 China: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 147 China: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 148 China: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 149 China: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 150 China: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 151 China: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 152 China: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 153 Japan: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 154 Japan: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 155 Japan: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 156 Japan: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 157 Japan: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 158 Japan: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 159 Japan: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 160 Japan: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 161 India: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 162 India: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 163 India: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 164 India: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 165 India: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 166 India: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 167 India: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 168 India: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 169 RoAPAC: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 170 RoAPAC: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 171 RoAPAC: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 172 RoAPAC: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 173 RoAPAC: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 174 RoAPAC: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 175 RoAPAC: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 176 RoAPAC: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 177 RoW: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 178 RoW: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 179 RoW: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 180 RoW: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 181 RoW: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 182 RoW: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 183 RoW: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 184 RoW: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 185 Product Launches, 2014–2017
Table 186 Partnerships and Agreements, 2014–2017
Table 187 Acquisitions, 2014–2017
Table 188 Expansions, 2014–2017

List of Figures (41 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Stem Cell Assays Market, By Type, 2018 vs 2023 (USD Billion)
Figure 7 Stem Cell Assays Market, By Cell Type, 2018 vs 2023 (USD Billion)
Figure 8 Stem Cell Assays Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 9 Stem Cell Assays Market, By Application, 2018 vs 2023 (USD Billion)
Figure 10 Stem Cell Assays Market, By End User, 2018 vs 2023 (USD Billion)
Figure 11 Stem Cell Assays Market, By Region, 2018 vs 2023 (USD Billion)
Figure 12 Availability of Funding for Stem Cell Research to Drive Market Growth During the Forecast Period
Figure 13 Flow Cytometers Accounted for the Largest Market Share in 2017
Figure 14 Isolation & Purification Assays to Register the Highest CAGR During the Forecast Period
Figure 15 Canada to Register the Highest CAGR During the Forecast Period
Figure 16 Stem Cell Assays Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 NIH Funding for Stem Cell Research in the Us, 2013 vs 2016 (USD Million)
Figure 18 Viability/Cytotoxicity Assays to Dominate the Market During the Forecast Period
Figure 19 Adult Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 20 Mesenchymal Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 21 Stem Cell Assay Instruments to Dominate the Market During the Forecast Period
Figure 22 Flow Cytometers to Dominate the Market During the Forecast Period
Figure 23 Regenerative Medicine & Therapy Development Segment to Dominate the Market During the Forecast Period
Figure 24 Biopharmaceutical & Biotechnology Companies to Dominate the Stem Cell Assays Market in 2023
Figure 25 North America to Dominate the Global Stem Cell Assays Market in 2018
Figure 26 North America: Stem Cell Assays Market Snapshot
Figure 27 Viability/Cytotoxicity Segment to Dominate the North American Stem Cell Assays Market in 2018
Figure 28 Europe: Stem Cell Assays Market Snapshot
Figure 29 Adult Stem Cells Segment to Dominate the European Stem Cell Assays Market in 2018
Figure 30 Asia Pacific: Stem Cell Assays Market Snapshot
Figure 31 Instruments Segment to Dominate the Asia Pacific Stem Cell Assays Market in 2018
Figure 32 RoW: Stem Cell Assays Market Snapshot
Figure 33 Regenerative Medicine & Therapy Development Segment to Dominate the RoW Stem Cell Assays Market in 2018
Figure 34 Market Share Analysis – 2016
Figure 35 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 36 Merck: Company Snapshot (2016)
Figure 37 GE Healthcare: Company Snapshot (2016)
Figure 38 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 39 Agilent Technologies: Company Snapshot (2017)
Figure 40 Perkinelmer: Company Snapshot (2016)
Figure 41 Bio-Techne Corporation: Company Snapshot (2017)



【レポートのキーワード】

幹細胞アッセイ

★調査レポート[幹細胞アッセイの世界市場予測（～2023年）] ( Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023 / MAM-BT-4628) 販売に関する免責事項
[幹細胞アッセイの世界市場予測（～2023年）] ( Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023 / MAM-BT-4628) についてEメールでお問い合わせ
◆関連調査資料◆
  • 幹細胞製造の世界市場予測（～2023年）：HSC、MSC、iPSC、ESC、装置、培地、消耗品
    BT-6089 / MarketsandMarkets / 2018年3月13日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞製造の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、幹細胞製造の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market. This report broadly segments the stem cell manufacturing market...
  • 試験管内肺モデルの世界市場予測（～2023年）
    BT6203 / MarketsandMarkets / 2018年4月25日 / MarketsandMarketsが発行した当調査レポートでは、試験管内肺モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（2D、3D）別分析、用途別分析、地域別分析、試験管内肺モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in cell culture technologies, and the development of new 3D in vitro models. The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house...
  • 細胞生存率アッセイの世界市場予測（～2023年）：MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計
    BT-6577 / MarketsandMarkets / 2018年9月5日 / MarketsandMarketsが発行した当調査レポートでは、細胞生存率アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計）分析、細胞タイプ（ヒト、動物、微生物）分析、用途（基礎研究、幹細胞、創薬・開発）分析、細胞生存率アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell viability assays market is projected to reach USD 4.16 billion by 2023 from USD 2.78 billion in 2018, at a CAGR of 8.4%. Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research, rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics. The report analyzes the global cell viability assays market by product, cell type, application, end user, and region. On the basis of product, the consumables segment is expected to account for the largest...
  • 神経科学用抗体＆アッセイの世界市場予測（～2023年）
    BT6283 / MarketsandMarkets / 2018年5月16日 / MarketsandMarketsが発行した当調査レポートでは、神経科学用抗体＆アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、装置）別分析、技術別分析、用途別分析、需要先別分析、神経科学用抗体＆アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. This report segments the neuroscience antibodies and assays market into product, technology, application, end user, and region. Based on product, the neuroscience antibodies and assays market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to...
  • マルチプレックスアッセイの世界市場予測（～2023年）
    BT-4473 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、装置）別分析、種類別分析、技術別分析、用途（研究開発、診断）別分析、マルチプレックスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the multiplex assays...
  • 幹細胞バンキングの世界市場予測（～2023年）
    BT4447 / MarketsandMarkets / 2018年5月15日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞バンキングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソース別分析、サービス種類別分析、用途別分析、地域別分析、幹細胞バンキングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%. Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market. This report broadly categorizes the global stem cell banking market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into...
  • 初代細胞の世界市場予測（～2023年）：造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉
    BT6489 / MarketsandMarkets / 2018年7月31日 / MarketsandMarketsが発行した当調査レポートでは、初代細胞の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別（ヒト、動物）分析、由来別（造血、血液、皮膚、消化器官、肝細胞、腎細胞、骨格・筋肉）分析、エンドユーザー別（ライフサイエンス研究、研究機関）分析、初代細胞の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. Growth in the primary cells market is mainly driven by factors such as increasing cancer research; the advantages of primary human cells over cell lines; the increasing demand for monoclonal antibodies; rapid growth in the biotechnology and biopharmaceutical industries, partnerships, collaborations, and acquisitions; and increasing pharmaceutical outsourcing. The global primary cells market is segmented by origin, type, end user, and region. By origin, the primary cells market is classified into hematopoietic, skin, gastrointestinal, liver, lung,...
  • 細胞採取の世界市場予測（～2023年）：種類、用途、エンドユーザー、地域別分析
    BT-6106 / MarketsandMarkets / 2018年3月20日 / MarketsandMarketsが発行した当調査レポートでは、細胞採取の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、用途別分析、需要先別分析、地域別分析、細胞採取の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays. The global cell harvesting market is expected to reach USD 324.5 Million by 2023 from USD 213.8 Million in 2018, at a CAGR of 8.7%. Rising investments in regenerative medicine and cell-based research, growth of the biopharmaceutical and biotechnology industry, and increasing incidence of chronic and infectious diseases are the major driving factors for this market. The cell harvesting market is segmented on the...
  • 細胞培養の世界市場予測（～2023年）：消耗品、装置、用途、地域別分析
    MAM-BT-2561 / MarketsandMarkets / 2018年4月13日 / MarketsandMarketsが発行した当調査レポートでは、細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、消耗品別分析、装置別分析、用途別分析、地域別分析、細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell culture market is expected to reach USD 26.28 Billion by 2023 from USD 15.32 Billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. This report segments the global market into product, application, end user, and region. Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share...
  • ハイスループットスクリーニング（HTS）の世界市場予測（～2023年）：細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス
    BT2220 / MarketsandMarkets / 2018年4月24日 / 当調査レポートでは、ハイスループットスクリーニング（HTS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術（細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス）別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニング（HTS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global high-throughput screening (HTS) market is projected to reach USD 21.69 Billion by 2023 from USD 14.87 Billion in 2018, at a CAGR of 7.8%. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments. The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆